VeriMomIst p-cresyl isovalerate in der Schwangerschaft sicher?
No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
Related ingredients
Frequently asked questions
- Ist p-cresyl isovalerate in der Schwangerschaft sicher?
- No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
- Ist p-cresyl isovalerate während des Stillens sicher?
- Same evidence base as pregnancy: no harmonised CMR classification or reproductive/developmental studies for this specific compound. Dermal exposure from cosmetic use is expected to be low but measurable (fragrance ester), so exposure = 1. No data showing secretion in milk or specific lactation effects.
- Ist p-cresyl isovalerate sicher für Babyhaut?
- No infant‑specific toxicity or developmental studies found. Following instructions to increase exposure for infants when adult absorption is measurable, exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and immature barrier function. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- Wie bewertet VeriMom p-cresyl isovalerate?
- VeriMom bewertet p-cresyl isovalerate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu p-cresyl isovalerate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu p-cresyl isovalerate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.